Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
epidural double lumen lidoderm scopolamine phenylepherene sciatica est pain control pregnancy intubationYour Article Summary
See Latest ArticlesBench-to-bedside review: Understanding the impact of resistance and virulence factors on MRSA infections in the ICU
Critical Care, 10/27/09
Skrupky LP et al. – Staphyloccocus aureus and MRSA can no longer be considered as solely a nosocomial pathogen. When initiating empiric antibiotics, it is of vital importance that this therapy be timely and appropriate, as delays in treatment are associated with adverse outcomes. Although vancomycin has long been considered a first–line therapy for serious MRSA infections, multiple concerns with this agent have opened the door for existing and investigational agents demonstrating efficacy in this role.
Today in Critical Care...keeping you current
Receive free subspecialty "5-minute updates" via email
Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery
Critical Care, 11/06/09
Inotrope and Vasopressor Therapy of Septic Shock
Critical Care Clinics, 11/09/09
Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: A meta-analysis of randomized controlled trials
Journal of Critical Care, 11/11/09
Article Search
Sponsor